medical-devices is the sole category represented across all 1 tracked stories. Aerolife Mini is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 6 runs below the beat's 6.3 for that window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about AeroDel
medical-devices is the sole category represented across all 1 tracked stories. Aerolife Mini is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 6 runs below the beat's 6.3 for that window. Source depth averages 3 original sources per story, versus 2.9 across the same-window beat baseline. AeroDel appears in 1 tracked Healthcare story from March 20, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering AeroDel. Shared-story counts are live from our verified record — not editorial picks.
AeroDel has entered into an exclusive licensing agreement with Zydus Lifesciences to launch the Aerolife Mini, a pioneering 'Always Attached' pMDI enhancer. The device is designed to improve medication delivery for respiratory patients by offering a portable, foldable solution that remains permanently fixed to the inhaler.